Wednesday, February 10, 2010, 9:08am EST - Canadian Markets open in 22 minutes.
To create a watchlist or portfolio of shares, Sign-in or Register

SCOLR Pharma Inc. (DDD)

 On Feb 9: 0.58 USD   0.00 (0.00%)  
MORE ON DDD
Quotes
HereSummary
Charts
News & Info
Company
Analyst Coverage
Ownership
Financials
SCOLR PHARMA INC (AMEX:DDD) Delayed quote dataEdit
Last Trade: 0.58 USD
Trade Time: Feb 9
Change: 0.00 (0.00%)
Prev Close: 0.58
Open: N/A
Bid: N/A
Ask: N/A
1y Target Est: 6.96
Day's Range: N/A - N/A
52wk Range: 0.25 - 0.85
Volume: 0
Avg Vol (3m): 50,957.1
Market Cap: 23.84M
P/E (ttm): N/A
EPS (ttm): -0.20
Div & Yield: N/A (N/A%)
SCOLR Pharma Inc. (DDD)
1d  5d  3m  6m  1y  2y  5y  max 
Free Annual Reports
 Add DDD to Portfolio   Download Data

HEADLINES
• SCOLR PHARMA, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement
EDGAR Online (Mon, Jan 4)
• SCOLR PHARMA, INC. Files SEC form 8-K, Change in Directors or Principal Officers
EDGAR Online (Wed, Dec 16)
• SCOLR Pharma, Inc. Licenses Dietary Supplements
PRNewswire (Tue, Dec 1)
• SCOLR PHARMA, INC. Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
EDGAR Online (Mon, Nov 30)
• SCOLR Pharma, Inc. Receives Notices From NYSE Amex LLC Regarding Compliance Plan and Listing Standards
PRNewswire (Mon, Nov 30)
• SCOLR PHARMA, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement
EDGAR Online (Wed, Nov 25)
• SCOLR PHARMA, INC. Financials
EDGAR Online Financials (Fri, Nov 13)
• SCOLR PHARMA, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibi
EDGAR Online (Mon, Nov 9)
• SCOLR PHARMA, INC. Files SEC form 10-Q, Quarterly Report
EDGAR Online (Fri, Nov 6)
• SCOLR PHARMA, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits
EDGAR Online (Tue, Nov 3)
More Headlines for DDD...
ANALYST
EPS Est (next year) (Dec-09) : -0.17
EPS Est (in 2 years) (Dec-10) : -0.10
Avg Rec (current)*: N/A
PEG Ratio: N/A
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

BUSINESS SUMMARY
SCOLR Pharma, Inc., a pharmaceutical company, develops and formulates prescription, over-the-counter, and nutritional products. The company uses its controlled delivery technology platform and develops water soluble and insoluble drugs, as well as...

Full Company Profile

Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Symbol Lookup
• Latest News • Canadian Indices